RE:RE:RE:RE:RE:Major discrepancy They did mention crop loss previously Trans, it is possible/probable there was more since and there is the genetics research, what kind of assets are involved in that work?....the genetics side of the company is expected to be huge so any funds/ assets invested there are definately not a loss but won't show up in the sales either and product in the vault would show as inventory.
There doesn't appear to be anything being done in weakness, no shortage of cash on hand or available to them which is more often the case than not. But this has been the pattern for this company from the start with Canaccord et al kicking just south of $100mil before they even made a sale and by all accounts it is much stronger, more recognized and higher valued going forward than any other in the sector, with possible exception of WEED, JMHO...Opt
theTransporter wrote: Another possibility is their annual capacity rates based on their footprint is flawed and needs re-evaluation as if they didn't have a crop loss (which signs do point to a significant crop loss), they are definetley not producing as much as they say they can per square foot.